Oruka Therapeutics, Inc. ORKA Net unrealized gains (losses) on securities still held
Net unrealized gains (losses) on securities still held at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s net unrealized gains (losses) on securities still held.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s net unrealized gains (losses) on securities still held?
- Oruka Therapeutics, Inc. (ORKA) reported net unrealized gains (losses) on securities still held of -$1.03M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s net unrealized gains (losses) on securities still held changed year-over-year?
- Oruka Therapeutics, Inc.'s net unrealized gains (losses) on securities still held decreased by 3031.4% year-over-year, from $35K to -$1.03M.
- What does net unrealized gains (losses) on securities still held mean?
- Tracks the change in the fair market value of investment securities held by the company that have not yet been sold. It provides insight into the unrealized performance of the company's investment portfolio due to market volatility.